Transcriptome changes in MCF7 cells after treatment with NONO ligands and controls
RNA-seq (gene expression) · human · 30 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 30 samples: 10 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Structural and mechanistic analysis of covalent ligands targeting the RNA-binding protein NONOCell chemical biology · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE299099_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1272574 and SRA study SRP590540. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 30 samples.
How we read this: 10 replicated groups read from 30 sample titles; they account for 30 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9032907 Total_RNAseq_MCF7_sgControl_6hours_R,R-GL-373_Replicate_1 Total_RNAseq_MCF7_sgCon…
- GSM9032908 Total_RNAseq_MCF7_sgControl_6hours_R,R-GL-373_Replicate_2 Total_RNAseq_MCF7_sgCon…
- GSM9032909 Total_RNAseq_MCF7_sgControl_6hours_R,R-GL-373_Replicate_3 Total_RNAseq_MCF7_sgCon…
- GSM9032910 Total_RNAseq_MCF7_sgControl_6hours_S,S-GL-373_Replicate_1 Total_RNAseq_MCF7_sgCon…
- GSM9032911 Total_RNAseq_MCF7_sgControl_6hours_S,S-GL-373_Replicate_2 Total_RNAseq_MCF7_sgCon…
- GSM9032912 Total_RNAseq_MCF7_sgControl_6hours_S,S-GL-373_Replicate_3 Total_RNAseq_MCF7_sgCon…
- GSM9032913 Total_RNAseq_MCF7_sgControl_6hours_DMSO_Replicate_1 Total_RNAseq_MCF7_sgCon…
- GSM9032914 Total_RNAseq_MCF7_sgControl_6hours_DMSO_Replicate_2 Total_RNAseq_MCF7_sgCon…
- GSM9032915 Total_RNAseq_MCF7_sgControl_6hours_DMSO_Replicate_3 Total_RNAseq_MCF7_sgCon…
- GSM9032916 Total_RNAseq_MCF7_sgControl_6hours_R-SKBG-1_Replicate_1 Total_RNAseq_MCF7_sgCon…
- GSM9032917 Total_RNAseq_MCF7_sgControl_6hours_R-SKBG-1_Replicate_2 Total_RNAseq_MCF7_sgCon…
- GSM9032918 Total_RNAseq_MCF7_sgControl_6hours_R-SKBG-1_Replicate_3 Total_RNAseq_MCF7_sgCon…
- GSM9032919 Total_RNAseq_MCF7_sgControl_6hours_S-SKBG-1_Replicate_1 Total_RNAseq_MCF7_sgCon…
- GSM9032920 Total_RNAseq_MCF7_sgControl_6hours_S-SKBG-1_Replicate_2 Total_RNAseq_MCF7_sgCon…
- GSM9032921 Total_RNAseq_MCF7_sgControl_6hours_S-SKBG-1_Replicate_3 Total_RNAseq_MCF7_sgCon…
- GSM9032922 Total_RNAseq_MCF7_sgNONO_6hours_R,R-GL-373_Replicate_1 Total_RNAseq_MCF7_sgNON…
- GSM9032923 Total_RNAseq_MCF7_sgNONO_6hours_R,R-GL-373_Replicate_2 Total_RNAseq_MCF7_sgNON…
- GSM9032924 Total_RNAseq_MCF7_sgNONO_6hours_R,R-GL-373_Replicate_3 Total_RNAseq_MCF7_sgNON…
- GSM9032925 Total_RNAseq_MCF7_sgNONO_6hours_S,S-GL-373_Replicate_1 Total_RNAseq_MCF7_sgNON…
- GSM9032926 Total_RNAseq_MCF7_sgNONO_6hours_S,S-GL-373_Replicate_2 Total_RNAseq_MCF7_sgNON…
- GSM9032927 Total_RNAseq_MCF7_sgNONO_6hours_S,S-GL-373_Replicate_3 Total_RNAseq_MCF7_sgNON…
- GSM9032928 Total_RNAseq_MCF7_sgNONO_6hours_DMSO_Replicate_1 Total_RNAseq_MCF7_sgNON…
- GSM9032929 Total_RNAseq_MCF7_sgNONO_6hours_DMSO_Replicate_2 Total_RNAseq_MCF7_sgNON…
- GSM9032930 Total_RNAseq_MCF7_sgNONO_6hours_DMSO_Replicate_3 Total_RNAseq_MCF7_sgNON…
- GSM9032931 Total_RNAseq_MCF7_sgNONO_6hours_R-SKBG-1_Replicate_1 Total_RNAseq_MCF7_sgNON…
- GSM9032932 Total_RNAseq_MCF7_sgNONO_6hours_R-SKBG-1_Replicate_2 Total_RNAseq_MCF7_sgNON…
- GSM9032933 Total_RNAseq_MCF7_sgNONO_6hours_R-SKBG-1_Replicate_3 Total_RNAseq_MCF7_sgNON…
- GSM9032934 Total_RNAseq_MCF7_sgNONO_6hours_S-SKBG-1_Replicate_1 Total_RNAseq_MCF7_sgNON…
- GSM9032935 Total_RNAseq_MCF7_sgNONO_6hours_S-SKBG-1_Replicate_2 Total_RNAseq_MCF7_sgNON…
- GSM9032936 Total_RNAseq_MCF7_sgNONO_6hours_S-SKBG-1_Replicate_3 Total_RNAseq_MCF7_sgNON…
- GSE307843 Transcriptomic profiling in MCF7 parent and RB1 knockout cells following treatment with abemaciclib 12 samples shares mcf7, treatment
- GSE334345 Exploratory investigation of changes in blood transcriptome following mepolizumab treatment for asthma 54 samples shares treatment, changes
- GSE305389 Stromal and Endothelial Transcriptional Changes during Progression from MGUS to Myeloma and after Treatment Response [RNA-Seq] 25 samples shares treatment, changes
- GSE334189 RNA-seq analysis of global gene expression changes in human FSHD immortalized myotubes following treatment with the BAZ1A inhibitor C06 18 samples shares treatment, changes
- GSE264573 Single Cell Analysis of Treatment–Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies 4 samples shares treatment, changes
- GSE283522 The spatially informed mFISHseq assay resolves biomarker discordance and predicts treatment response in breast cancer 1254 samples shares treatment
- GSE171741 Albumin treatment transcriptionally reprograms circulating immune cells in patients with acutely decompensated cirrhosis 139 samples shares treatment
- GSE310252 Transcriptome-based classification of resected pancreatic ductal adenocarcinoma enhances prognostic modelling accuracy of overall survival following adjuvant treatment 118 samples shares treatment
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.